Overall volumes in futures & options currently stand at 1.33 crore contracts with a turnover of Rs. 13,57,421.34 crore.

Going ahead, the level of 11,390-11,400 is likely to act as immediate support for the index. On the upside, immediate resistance for the index is seen around 11,505, which is its 21-day EMA, and sustaining above this level may result in further upmove up to the levels of 11,530-11,550.  Stocks in news: Aurobindo Pharma, Nandan Denim, Alembic Pharmaceuticals, Persistent Systems, Welspun Corp, PSP Projects, Bharti Infratel and Bharti Airtel.

Indian shares are expected to open modestly higher on Thursday, shrugging off weak global cues. The SGX Nifty suggests that Nifty could open higher by 39 points around the level of 11,542.

Angel Broking Limited, a leading broking house has filed a Draft Red Herring Prospectus (DRHP) with SEBI.

Major indices have witnessed bloodbath from the start of this week. For the third consecutive day on Wednesday, the indices have shed considerable gains. Where the benchmark indices Nifty and Sensex tumbled more than 3 per cent, BSE Midcap index underperformed by plunging nearly 5.5 per cent.

Centrum Financial Services Limited signed an agreement to acquire L&T Finance's Supply Chain Finance business on Wednesday. The supply chain vertical provides working capital finance to entities that are suppliers to large industrial manufacturers and Original Equipment Manufacturers (OEMs). The company also provide channel finance and inventory finance to dealers. Its combined customer base is nearly about 800.

The Thomas Cook (India) Group announced the reduction of debt making it debt-free by September 30, 2018. The group will pre-pay Rs. 67 crore non-convertible debentures.

Following stocks are close to their 52-week low as at 1.02 p.m. on September 05, 2018.

The markets on September 05, 2018 opened up. BSE Sensex is trading at 37,893.59, down by 264.33 points and the Nifty is trading at 11,440.85, down by 79.45 points. 

The company is having a strong pipeline of products in the extended-release space and this is the second extended-release product approval for the company.